We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. OK, I agree | Cookies Policy



Congresses: Noventure participates at NeuroGASTRO 2017, Cork, Ireland, with an innovative approach to IBS

Noventure, as part of its continued commitment to Gastroenterology, participated at the recent NeuroGASTRO 2017 meeting, which brought together leading experts and young investigators in neurogastroenterology, digestive motility and functional gastrointestinal diseases from Europe and from all around the world. The new product Gelsectan® was depicted at the Noventure´s stand as a teaser campaign, under the motto “Mucoprotection”.

Read more

Gelsectan® Launched In Spain

We are pleased to announce the launch of our new IBS product Gelsectan® in its first market, Spain. The product is distributed by Norgine, as part of an agreement signed last March: http://noventure.com/corporate-press-release-norgine-and-noventure-enter-agreement-commercialize-gelsectanr-spain

Read more

Let's meet in..

2019, Nov 05

CPhI 2019

Read more

2019, Nov 25

euroPLX 71

Read more

2019, Nov 28

PharmaVenue November 2019

Read more